V03AAll Other Therapeutic Products
Subgroups
- AntidotesV03AB
- Iron chelating agentsV03AC
- Drugs for treatment of hyperkalemia and hyperphosphatemiaV03AE
- Detoxifying agents for antineoplastic treatmentV03AF
- Drugs for treatment of hypercalcemiaV03AG
- Drugs for treatment of hypoglycemiaV03AH
- Tissue adhesivesV03AK
- Drugs for embolisationV03AM
- Medical gasesV03AN
- Other therapeutic productsV03AX
- Nerve depressantsV03AZ
Substances
- oxygenV03AN01
- ethanolV03AB16
- nitrogenV03AN04
- deferasiroxV03AC03
- naloxoneV03AB15
- carbon dioxideV03AN02
- potassium iodideV03AB21
- sugammadexV03AB35
- calcium acetateV03AE07
- methylene blueV03AB17
- flumazenilV03AB25
- lanthanum carbonateV03AE03
- heliumV03AN03
- sevelamerV03AE02
- deferiproneV03AC02
- glutathioneV03AB32
- dexrazoxaneV03AF02
- mesnaV03AF01
- amyl nitriteV03AB22
- deferoxamineV03AC01
- fomepizoleV03AB34
- cobicistatV03AX03
- sodium zirconium cyclosilicateV03AE10
- diazoxideV03AH01
- hydroxocobalaminV03AB33
- phentolamineV03AB36
- glucarpidaseV03AF09
- rasburicaseV03AF07
- trilaciclibV03AF12
- amifostineV03AF05
- andexanet alfaV03AB38
- difelikefalinV03AX04
- paliferminV03AF08
- potassium permanganateV03AB18
- sodium nitriteV03AB08
- sodium phosphateV03AG05
- pralidoximeV03AB04
- sucroferric oxyhydroxideV03AE05
- 4-dimethylaminophenolV03AB27
- dimercaprolV03AB09
- physostigmineV03AB19